The development of dynamic nuclear polarization (DNP) in solution has enabled in vivo 13 C MR studies at high signal to noise ratio (SNR) following injection of pre-polarized 13 C substrates. While prior studies have demonstrated the ability to observe metabolism following injection of hyperpolarized 13 C-pyruvate, the goal of this study was to develop and test a new hyperpolarized agent for investigating in vivo metabolism, [1-13 C] lactate. A preparation for pre-polarized 13 Clactate and the requisite dissolution media were developed to investigate the feasibility for in vivo 13 C MRS/MRSI studies following injection of this hyperpolarized agent. This study demonstrated, for the first time, not only the ability to detect hyperpolarized [1-13 C] lactate in vivo, but also the metabolic products 13 C pyruvate, 13 C alanine and 13 C bicarbonate following injection in normal rats. Using 13 C-lactate as a substrate provided the ability to study the conversion of lactate to pyruvate in vivo and to detect the secondary conversions to alanine and bicarbonate through pyruvate. This study also demonstrated the potential value of this hyperpolarized agent to investigate in vivo lactate uptake and metabolism in pre-clinical animal models.